MLchartDataset catalogue

Elzonris

Term · Oncology and biomedicine · MLC-T-ONC-002758

A drug used to treat adults and children aged 2 years and older with a rare blood cancer called blastic plasmacytoid dendritic cell neoplasm. It is also being studied in the treatment of other types of cancer. Elzonris is made up of interleukin-3 (IL-3), which binds to an IL-3 receptor protein called CD123. CD123 may be found in higher than normal amounts on some types of cancer cells. Elzonris is also made up of a diphtheria toxin, which may help kill cancer cells. Elzonris is a type of cytotoxin. Also called tagraxofusp.

Table 1. Record
IdentifierMLC-T-ONC-002758
FieldOncology and biomedicine
Synonymstagraxofusp
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002758",
  "term": "Elzonris",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults and children aged 2 years and older with a rare blood cancer called blastic plasmacytoid dendritic cell neoplasm. It is also being studied in the treatment of other types of cancer. Elzonris is made up of interleukin-3 (IL-3), which binds to an IL-3 receptor protein called CD123. CD123 may be found in higher than normal amounts on some types of cancer cells. Elzonris is also made up of a diphtheria toxin, which may help kill cancer cells. Elzonris is a type of cytotoxin. Also called tagraxofusp.",
  "synonyms": [
    "tagraxofusp"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/elzonris/"
}

Record 6,565 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.